CVS Group PLC
LSE:CVSG

Watchlist Manager
CVS Group PLC Logo
CVS Group PLC
LSE:CVSG
Watchlist
Price: 1 132 GBX Market Closed
Market Cap: £794.2m

CVS Group PLC
Investor Relations

CVS Group Plc is a holding company, which engages in the provision of veterinary services. The company is headquartered in Diss, Norfolk and currently employs 7,241 full-time employees. The company went IPO on 2007-10-10. The firm operates in the four business segments, namely Veterinary Practices, Laboratories, Crematoria and Online Retail Business. The company offers an integrated model with approximately 500 veterinary practices across its three territories, including eight specialist referral hospitals and 34 out-of-hours sites. Veterinary Practices provide specialist treatment for companion, equine and farm animals. The firm laboratories provide diagnostic services to CVS veterinary practices and third parties. The company offers a range of tests with the ability to tailor specific profiles to its customers' needs. Its crematoria provide pet cremation and clinical waste services to CVS practices and third-party practices, and cremations to animal owners. CVS online retail business, Animed Direct, sells prescription and nonprescription medicines, pet foods and a range of pet care products.

Show more
Loading
CVSG
FTSE All Share Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Feb 26, 2026
AI Summary
Q2 2026

Revenue: Revenue grew to GBP 356.9 million, up 5.8% YoY, driven by acquisitions and like‑for‑like growth of 2.7%.

Profitability: Adjusted EBITDA rose to GBP 67.7 million (up 3.9%) with an adjusted EBITDA margin of 19%, remaining within the group's 19%–23% ambition despite wage and NIC cost headwinds.

Cash & Balance Sheet: Free cash flow improved to GBP 34.4 million (up 16.2%); net bank borrowings rose to GBP 160.2 million and leverage is 1.41x, comfortably below the 2x ceiling.

Growth & M&A: Australia is a key focus — now 33 practices across 55 sites, representing circa 10% of group revenue and circa 15% of group EBITDA; GBP 23.3 million spent on acquisitions in H1 and management expects further deals.

Regulatory/CMA: The CMA provisional decision in Oct 2025 brought certainty; management disagrees with some remedies (eg, prescription fee cap) but is comfortable and is cooperating ahead of the final decision.

Brand & People: Launched consumer-facing CVS Vets brand (circa 60 practices rebranded so far); client NPS improved to 81.2 and employee NPS to +10 (ahead of FY26 target of +5).

Operational initiatives: Continued investment in practice relocations/refurbishments and clinical equipment (GBP 17.5 million in H1) and ongoing research agenda including antimicrobial stewardship projects.

Key Financials
Revenue
GBP 356.9 million
Like‑for‑like sales growth
plus 2.7%
Adjusted EBITDA
GBP 67.7 million
Adjusted EBITDA margin
19%
Free cash flow
GBP 34.4 million
Operating cash conversion
75%
Net bank borrowings
GBP 160.2 million
Leverage
1.41x
Adjusted EPS
40.2p
Capital expenditure (H1)
GBP 17.5 million
Consideration for acquisitions (H1)
GBP 23.3 million
Australia share of group revenue
circa 10% of group revenue
Australia share of group EBITDA
circa 15% of group EBITDA
Client Net Promoter Score
81.2
Employee Net Promoter Score
10
Committed debt facility
GBP 350 million
Hedged debt
GBP 100 million swapped to fixed at circa 5.5% through to February 2028
Other Earnings Calls
2026
2025

Management

Mr. Richard William Mark Fairman F.C.A.
CEO & Director
No Bio Available
Mr. Robin Jay Alfonso F.C.A.
CFO & Director
No Bio Available
Mr. Paul Higgs
Chief Veterinary Officer
No Bio Available
Charlotte Page
Group Financial Controller & Head of Investor Relations
No Bio Available
Mr. Scott Morrison
Group General Counsel & Company Secretary
No Bio Available
Ms. Helen Finney
Group HR Director
No Bio Available
Mr. Gordon Palmer
Head of IT
No Bio Available
James Cahill
MVB - Managing Director of CVS International
No Bio Available
Mr. Robert Dawson
Small Animal Director
No Bio Available
Ms. Elizabeth McLennan-Green
Small Animal Veterinary Director
No Bio Available

Contacts

Address
NORFOLK
Diss
C V S House, Owen Road
Contacts
+441379644288.0
www.cvsukltd.co.uk
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett